ArticleThe World Allergy Organization journal2021

Rapid transition to home omalizumab treatment for chronic spontaneous urticaria during the COVID-19 pandemic: A patient perspective.

Catherine King et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.